BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 2614988)

  • 21. [A case of systemic lupus erythematosus (SLE) developing pan-dysautonomia].
    Jodo S; Sagawa A; Ogura N; Atsumi T; Amasaki Y; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S
    Ryumachi; 1992 Feb; 32(1):58-65. PubMed ID: 1604418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of methotrexate in patients with systemic lupus erythematosus and primary Sjögren's syndrome.
    Winzer M; Aringer M
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S156-9. PubMed ID: 21044451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sjögren's syndrome in dermatology.
    Fox RI; Liu AY
    Clin Dermatol; 2006; 24(5):393-413. PubMed ID: 16966020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cyclosporin in autoimmune diseases].
    Frey FJ
    Schweiz Med Wochenschr; 1990 May; 120(21):772-86. PubMed ID: 2190313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases.
    Filippini P; Del Papa N; Sambataro D; Del Bufalo A; Locatelli F; Rutella S
    Curr Med Chem; 2012; 19(31):5381-93. PubMed ID: 22963664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis.
    Seibold JR; McCloskey DA
    Curr Opin Rheumatol; 1997 Nov; 9(6):571-5. PubMed ID: 9375287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of immunomodulating therapy in systemic sclerosis.
    van den Hoogen FH; Boerbooms AM; van de Putte LB
    Clin Rheumatol; 1990 Sep; 9(3):319-24. PubMed ID: 2124530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of overlap syndrome of PSS, SLE and Sjögren syndrome treated by cyclosporin A: an improvement of sclerosis of the skin].
    Kume A; Ueda K; Sano S; Funai T; Kobayashi Y; Hashimoto K; Yoshikawa K
    Nihon Hifuka Gakkai Zasshi; 1989 Oct; 99(11):1191-6. PubMed ID: 2614988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
    Rosenthal M
    J Rheumatol Suppl; 1978; 4():97-100. PubMed ID: 366146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inclusion body myositis in connective tissue disorders: case report and review of the literature.
    Derk CT; Vivino FB; Kenyon L; Mandel S
    Clin Rheumatol; 2003 Oct; 22(4-5):324-8. PubMed ID: 14576992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune rheumatic diseases in women.
    Schuna AA
    J Am Pharm Assoc (Wash); 2002; 42(4):612-23; quiz 623-4. PubMed ID: 12150360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
    Zintzaras E; Voulgarelis M; Moutsopoulos HM
    Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.